RxDoctor Payments Data

Barbara Bennett, DO

Family Medicine · Dayton, OHNPI 1003819525

Payments from drug & device makers

$16,492in general payments, 2019–2025

Across 1,159 payments — averaging $14.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Amgen$886
  • Pfizer$829
  • Sunovion Pharmaceuticals Inc.$689
  • Bayer$688
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$16,34399%
  • Education$1491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca108$2,371
AbbVie(2 entities)189$2,245
Amgen68$886
Pfizer75$829
Sunovion Pharmaceuticals Inc.70$689
Bayer56$688
Dexcom, Inc.28$679
Astellas Pharma US Inc33$675
Novo Nordisk50$619
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC45$540
GSK40$503
Otsuka America Pharmaceutical, Inc.26$413
Johnson & Johnson28$409
Lilly USA, LLC23$391
Amarin Pharma, Inc.30$353
Boehringer Ingelheim21$349
Takeda Pharmaceuticals U.S.A., Inc.21$306
Mylan Specialty L.p.27$294
Biohaven Pharmaceutical Holding Company Ltd.28$265
Kowa Pharmaceuticals America, Inc.13$231
Biohaven Pharmaceuticals, Inc.31$219
Merck14$205
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)18$190
Abbott9$169
Exact Sciences8$159
Lundbeck LLC6$138
Almatica Pharma LLC6$127
Novartis6$120
Axsome Therapeutics, Inc.5$108
Sumitomo Pharma America, Inc.5$95
Phathom Pharmaceuticals, Inc.4$78
Viatris Specialty LLC4$75
Arbor Pharmaceuticals, Inc.1$70
Paratek Pharmaceuticals, Inc.3$64
Renalytix AI, Inc.3$62
Xeris Pharmaceuticals, Inc.4$55
Mannkind Corporation3$51
E.r. Squibb & Sons, L.L.C.3$48
Idorsia Pharmaceuticals US Inc3$47
Ironshore Pharmaceuticals Inc.3$46
Shield Therapeutics Inc3$46
Amphastar Pharmaceuticals, Inc.3$41
Sanofi-aventis U.S. LLC3$41
Medtronic(2 entities)2$38
Scilex Pharmaceuticals Inc.3$36
Amneal Pharmaceuticals LLC2$35
Optinose US, Inc.2$35
Alkermes, Inc.2$35
Aimmune Therapeutics, Inc.2$33
Endo Pharmaceuticals Inc.2$33
Corium, LLC2$27
Grifols USA, LLC1$25
Ironwood Pharmaceuticals, Inc2$24
Verona Pharma, Inc.1$19
Insulet Corporation1$19
Daiichi Sankyo Inc.1$17
Azurity Pharmaceuticals, Inc.1$17
Nestle Healthcare Nutrition Inc.1$16
Tris Pharma Inc1$16
Vertical Pharmaceuticals, LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,492 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$53,122
Medicare patients
224
Services billed
3,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$101,185
TrulicityDulaglutide62$71,704
EliquisApixaban70$70,089
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$59,002
MounjaroTirzepatide41$48,736
JardianceEmpagliflozin42$42,271
Breztri AerosphereBudesonide/Glycopyr/Formoterol34$35,214
XareltoRivaroxaban33$29,747
RexultiBrexpiprazole16$28,147
JanuviaSitagliptin Phosphate28$24,206
JanumetSitagliptin Phos/Metformin Hcl20$19,775
FarxigaDapagliflozin Propanediol26$19,150
LinzessLinaclotide16$16,996
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$13,117
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$11,358

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$391$120,441103 claims
Novo NordiskOzempic, Levemir$619$104,30084 claims
PfizerEliquis$829$70,08970 claims
GSKTrelegy Ellipta, Breo Ellipta$503$69,35889 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$2,371$59,52578 claims
Boehringer IngelheimJardiance, Combivent Respimat$349$47,43153 claims
MerckJanuvia, Janumet$205$43,98148 claims
Johnson & JohnsonXarelto$409$29,74733 claims
Otsuka America Pharmaceutical, Inc.Rexulti$413$28,14716 claims
AbbVieLinzess, Synthroid$2,245$19,29140 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$35$4,201455 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →